Identification of germline missense mutations and rare allelic variants in the ATM gene in early‐onset breast cancer

Epidemiological studies have shown an increased risk of breast cancer in obligate ataxia telangiectasia (A‐T) heterozygotes. We analyzed 100 samples from young breast cancer patients for mutations in ataxia‐telangiectasia mutated (ATM), the gene responsible for the autosomal recessive condition, A‐T, to determine whether A‐T heterozygosity predisposes such individuals to develop breast cancer. These patients were selected from families with a moderate or absent family history of breast cancer and included a subset of 16 radiosensitive patients. Forty‐four germline sequence variants were detected by fluorescent chemical cleavage of mismatch of RT‐PCR products. These included seven rare variants found in nine patients (three described for the first time), but no truncating mutations. Although three variants were detected in the radiosensitive subset, this was not statistically significant compared to the nonradiosensitive group. One variant, G2765S, is likely to be a missense mutation, but the other six variants probably represent rare polymorphisms. However, five of the seven rare germline variants detected showed loss of heterozygosity of the wild‐type ATM allele for one or more markers close to the ATM locus in matched tumor DNA. This high rate of somatic inactivation of ATM may indicate either that these rare variants play a role in breast cancer development or alternatively that a neighboring tumor suppressor gene is important for tumorigenesis. We found germline truncating ATM mutations to be rare in these young breast cancer patients and therefore they are unlikely to play a role in the etiology of their disease. Genes Chromosomes Cancer 26:286–294, 1999. © 1999 Wiley‐Liss, Inc.

[1]  S. Hodgson,et al.  Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations , 1999, European Journal of Human Genetics.

[2]  S. Seal,et al.  Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. , 1998, British Journal of Cancer.

[3]  M. Lavin,et al.  Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  A. Lindblom,et al.  The role of ataxia-telangiectasia heterozygotes in familial breast cancer. , 1998, Cancer research.

[5]  C. Mathew,et al.  Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer , 1998, Genes, chromosomes & cancer.

[6]  D. Easton,et al.  ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. , 1998, American journal of human genetics.

[7]  M. Dyer,et al.  Clustering of missense mutations in the ataxia-telanglectasia gene in a sporadic T-cell leukaemia , 1997, Nature Genetics.

[8]  Y. Shiloh,et al.  Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. , 1997, Genome research.

[9]  A. Børresen-Dale,et al.  Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM , 1997, Genes, chromosomes & cancer.

[10]  K. Isselbacher,et al.  Heterozygous ATM mutations do not contribute to early onset of breast cancer , 1997, Nature Genetics.

[11]  M. Swift,et al.  Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. , 1996, Cancer genetics and cytogenetics.

[12]  I. Ellis,et al.  High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. , 1996, Cancer research.

[13]  C. Croce,et al.  ATM mutations in cancer families. , 1996, Cancer research.

[14]  F. Collins,et al.  Identification and chromosomal localization of Atm, the mouse homolog of the ataxia-telangiectasia gene. , 1996, Genomics.

[15]  M. James,et al.  The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. , 1996, Cancer research.

[16]  F. Collins,et al.  The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. , 1995, Human molecular genetics.

[17]  D. Eccles,et al.  Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. , 1995, British Journal of Cancer.

[18]  G. Hampton,et al.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.

[19]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[20]  G. Hampton,et al.  A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. , 1995, Cancer research.

[21]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[22]  G. Chenevix-Trench,et al.  Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours. , 1994, British Journal of Cancer.

[23]  G. Hampton,et al.  Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Taylor,et al.  Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. , 1993, British Journal of Cancer.

[25]  D Morrell,et al.  Incidence of cancer in 161 families affected by ataxia-telangiectasia. , 1991, The New England journal of medicine.

[26]  M. Baudis,et al.  Modification of enzymatically amplified DNA for the detection of point mutations. , 1989, Nucleic acids research.

[27]  A. Hall,et al.  Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. , 1988, Cancer research.

[28]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  P. Parsons,et al.  Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia. , 1998, British Journal of Cancer.

[31]  T. Stankovic,et al.  Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. , 1997, British Journal of Cancer.

[32]  Y. Shiloh,et al.  The genetic defect in ataxia-telangiectasia. , 1997, Annual review of immunology.

[33]  R. Cowan,et al.  A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. , 1995, International journal of radiation biology.

[34]  R. Cowan,et al.  Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. , 1995, International journal of radiation biology.

[35]  D. Easton Cancer Risks in A-T Heterozygotes. , 1994, International journal of radiation biology.